Skip to main content
D.Western Therapeutics Institute, Inc. logo

D.Western Therapeutics Institute, Inc. — Investor Relations & Filings

Ticker · 4576 ISIN · JP3548740004 T Professional, scientific and technical activities
Open in API
Filings indexed 69 across all filing types
Latest filing 2017-11-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 4576

About D.Western Therapeutics Institute, Inc.

https://dwti.co.jp/english/

D.Western Therapeutics Institute, Inc. is a biotechnology company focused on the research, discovery, and development of innovative pharmaceutical drugs. The company's core technology is centered on a proprietary compound library with a primary focus on inhibitors, particularly protein kinase inhibitors. Its drug discovery and development business aims to provide patients with more effective and beneficial treatments than conventional drugs. A notable product developed from its research is the ophthalmic solution GLANATEC.

Recent filings

Filing Released Lang Actions
四半期報告書－第20期第3四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 20th fiscal year, filed with the Tokai Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-10 Japanese
四半期報告書－第20期第2四半期(2017/04/01－2017/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for D.Western Therapeutics Institute, Inc. for the second quarter of 2017. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management's analysis of the financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-08-10 Japanese
四半期報告書－第20期第1四半期(2017/01/01－2017/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for D.Western Therapeutics Institute, Inc. covering the first quarter of the 20th fiscal year (January 1, 2017, to March 31, 2017). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements and management analysis. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. Q1 2017
2017-05-15 Japanese
有価証券報告書－第19期(2016/01/01－2016/12/31)
Annual Report Classification · 1% confidence The document is a 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, management discussion, business overview, and historical financial data for the fiscal year ending December 31, 2016. It is a formal regulatory filing submitted to the Tokai Finance Bureau under the Financial Instruments and Exchange Act. FY 2016
2017-03-23 Japanese
四半期報告書－第19期第3四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '第３四半期報告書' (Third Quarter Report) filed by D.Western Therapeutics Institute, Inc. It contains detailed financial statements, including the balance sheet, income statement, and notes to the financial statements for the third quarter period ending September 30, 2016. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-11-11 Japanese
四半期報告書－第19期第2四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the second quarter of the 19th fiscal period, covering the period from April 1, 2016, to June 30, 2016. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2016
2016-08-10 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.